Two swelling treatments affect brain tumors in different ways
Original title: Differential modulation of glioma metabolism and the tumor microenvironment following dexamethasone and bevacizumab treatment.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
The main findings came from mice and from cells in the lab, plus a look at tumor tissue from a small number of patients.
The short version
Two drugs used for brain swelling seem to have very different effects on the immune system around a tumor.
What was studied. Researchers looked at two drugs used to control swelling in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. One is dexamethasone, a steroid. The other is bevacizumab, used as a way to avoid steroids. They tested tumor tissue from patients, cells in the lab, and mice with brain tumors.
What they found. Tumors from 12 patients who got the steroid were compared with tumors from 18 patients who got no steroid. The steroid group showed nine changed chemicals in the tumor, a sign the tumor was more active. In mice, the steroid lowered the number of immune T cells inside the tumor. Bevacizumab did the opposite. It brought more active immune cells into the tumor, and immune cells from those mice killed more tumor cells in lab dishes.
What this means, and what it doesn't
What it could mean: How swelling is treated may also change how the immune system acts around a tumor. That could matter most for people who are also getting immune based treatment. This is something to ask your doctor about, not something to change on your own. Steroids are still the routine treatment for swelling, and stopping them suddenly can be dangerous.
What it doesn't mean: This does not mean one drug is better than the other for you. Most of the immune findings came from mice and from cells in the lab, not from people. The human part was a look at tissue from a small number of patients, not a trial testing which drug helps people live longer or feel better. Nothing here shows either drug is a cure, and it does not change what care you can get today.
Source: PubMed, June 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.